1st Apr 2008 15:33
ReGen Therapeutics PLC01 April 2008 1 April 2008 REGEN THERAPEUTICS PLC ("ReGen" or the "Company"; Ticker: (RGT)) TR-1(i): NOTIFICATION OF MAJOR INTEREST IN SHARES 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached (ii): ReGen Therapeutics Plc 2. Reason for the notification: An acquisition or disposal of voting rights and an event changing the breakdown of voting rights. 3. Full name of person(s) subject to the notification obligation (iii): Barclays PLC 4. Full name of shareholder(s) (if difference from 3): Barclays Stockbrokers LtdGerrard Investment Management Ltd 5. Date of the transaction and date on which the threshold is crossed or reached (v): 31 March 2008 6. Date on which issued notified: 1 April 2008 7. Threshold(s) that is/are crossed or reached: 6% to 5% 8. Notified details A: Voting rights attached to shares Class/type of share if possible using the ISIN Code GB00B28XMY25 Situation Previous to the triggering transaction (vi) - Number of Shares 631,501 Number of Voting Rights (viii) 631,501 Resulting situation after the triggering transaction (viii) - Number of Shares 641,501 Number of Voting Rights - Direct (x) N/A Number of Voting Rights - Indirect (xi) 641,501 % of voting rights - Direct N/A % of voting rights - Indirect 5.75 B: Financial Instruments Resulting situation after the triggering transaction (xii) Type of financial instrument N/A Expiration date (xiii) N/A Exercise/Conversion Period/Date (xiv) N/A Number of voting rights that may be acquired if theinstrument is exercised/converted N/A % of voting rights N/A Total (A+B) Number of voting rights 641,501 % of voting rights 5.75 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable (xv): Barclays Stockbrokers LtdGerrard Investment Management Ltd Proxy Voting: 10. Name of the proxy holder: N/A 11. Number of voting rights proxy holder will cease to hold: N/A 12. Date on which proxy holder will cease to hold voting rights: N/A 13. Additional information: N/A 14. Contact name: Geoff Smith 15. Contact telephone number: 0207 116 2913 For further information: For further information, please contact: Percy LomaxReGen Therapeutics PlcTel: 020 7153 4920 Roland Cornish/Felicity GeidtBeaumont Cornish LimitedTel: 020 7628 3396 This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
TILS.LBarclays